CCNG2 and ovarian carcinoma: METTL3 and METTL14 form a stable heterodimer to affect the metastatic potential of cancer cells via distinct mechanism [35, 36], for example, METTL3 promoted the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression [37].